THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company was founded in April 2005 and is headquartered in Thousand Oaks, CA.
The current price of CBDG is 0.0427 USD — it has decreased by 0.70% in the past 24 hours. Watch THC Farmaceuticals, Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange THC Farmaceuticals, Inc stocks are traded under the ticker CBDG.
CBDG stock is 0.70% volatile and has beta coefficient of 36.91. Track THC Farmaceuticals, Inc stock price on the chart and check out the list of the most volatile stocks — is THC Farmaceuticals, Inc there?
CBDG stock has fallen by 0.70% compared to the previous week, the month change is a 165.22% rise, over the last year THC Farmaceuticals, Inc has showed a 3.46 K% increase.
Today THC Farmaceuticals, Inc has the market capitalization of 774.22 K, it has decreased by 31.51% over the last week.
No, CBDG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CBDG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THC Farmaceuticals, Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THC Farmaceuticals, Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THC Farmaceuticals, Inc stock shows the sell signal. See more of THC Farmaceuticals, Inc technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.